{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Takeda Pharmaceutical Company Limited"},"Symbol":{"label":"Symbol","value":"TAK"},"Address":{"label":"Address","value":"1-1, NIHONBASHI-HONCHO 2-CHOME,CHUO-KU, TOKYO, 103-8668, Japan"},"Phone":{"label":"Phone","value":"+81 332782306"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Asia"},"CompanyDescription":{"label":"Company Description","value":"Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 3.6 trillion in fiscal 2021. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada."},"CompanyUrl":{"label":"Company Url","value":"https://www.takeda.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Andrew S. Plump","title":"Director, President-Research & Development"},{"name":"Christophe Weber","title":"President, CEO & Representative Director"},{"name":"Gabriele Ricci","title":"Chief Data & Technology Officer"},{"name":"Mark Etherton","title":"Medical Director"},{"name":"Michael E. Mendelsohn","title":"Chief Medical & Scientific Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}